Wilcoxon’s Rank Test between T0 and T1, i_e_ after 14 weeks of administered outcome measures
| Measure | T0 Mean (SD) | T1 Mean (SD) | T0 Median | T1 Median | p-value | Effect Size |
|---|---|---|---|---|---|---|
| Static Balance -TCT | 4.47 (1.96) | 4.53 (1.92) | 6.00 | 6.00 | 0.32 | −1000 |
| Dynamic Balance - TCT | 4.60 (1.84) | 4.70 (1.71) | 5.00 | 5.00 | 0.32 | −1000 |
| Reaching -TCT | 8.40 (3.62) | 8.40 (3.62) | 9 | 9 | 1.00 | n.c. |
| TCT Total | 17.47 (6.84) | 17.67 (6.68) | 20 | 20 | 0.32 | −1000 |
| SCIM Self-Care | 15.50 (4.45) | 16.13 (4.72) | 16 | 17 | 0.034* | −1000 |
| SCIM Sphincter–Breathing | 32.80 (6.28) | 33.50 (6.56) | 36 | 36 | 0.07 | −1000 |
| SCIM Mobility | 17.33 (6.40) | 18.60 (6.09) | 18 | 18 | 0.017* | −1000 |
| SCIM Total | 65.60 (15.21) | 68.27 (15.53) | 72 | 72 | 0.018* | −1000 |
| WheelCon-M Physical | 86.73 (39.51) | 93.33 (40.88) | 99 | 106 | 0.015* | −0.911 |
| WheelCon-M Social | 58.60 (25.71) | 64.73 (26.74) | 67 | 73 | 0.012* | −1000 |
| WheelCon-M Total | 145.33 (63.60) | 158.07 (66.45) | 158 | 179 | 0.011* | −0.956 |
| SF-36 Physical Functioning | 26.3 (17.3) | 41.0 (20.4) | 20 | 40 | 0.002* | −1000 |
| SF-36 Role Limitation | 40.0 (41.0) | 70.0 (39.2) | 25 | 75 | 0.026* | −1000 |
| SF-36 Energy/Fatigue | 63.3 (16.0) | 71.0 (16.3) | 60 | 65 | 0.006* | −0.846 |
| SF-36 Emotional Well-Being | 68.3 (17.8) | 77.3 (16.6) | 68 | 76 | 0.002* | −1000 |
| SF-36 Social Functioning | 58.3 (17.5) | 73.3 (12.4) | 62.5 | 75 | 0.011* | −1000 |
| SF-36 Pain | 62.7 (14.2) | 73.5 (20.9) | 67.5 | 67.5 | 0.024* | −0.800 |
| SF-36 General Health | 62.7 (17.9) | 73.0 (18.1) | 70 | 75 | 0.002* | −1000 |
| SF-36 Health Change | 81.7 (24.0) | 91.7 (12.2) | 100 | 100 | 0.014* | −1000 |
| MSES Daily Life | 49.73 (8.61) | 38.13 (5.78) | 52 | 38 | 0.001* | 0.981 |
| MSES Social Functioning | 38.40 (9.33) | 58.27 (9.05) | 41 | 61 | 0.001* | −1000 |
| MSES Total | 88.13 (17.26) | 96.40 (12.22) | 94 | 99 | 0.003* | −1000 |
Demographic characteristics of the 15 included participants
| Parameter | Frequency (%) |
|---|---|
| Sex ratio – female: male | 3 (20%): 12 (80%) |
| Lesion levela | |
| C4 | 1 (6.7%) |
| D3–D9 | 10 (66.8%) |
| D11 | 1 (6.7%) |
| L1 | 1 (6.7%) |
| L2 | 1 (6.7%) |
| T1 | 1 (6.7%) |
| AISb | |
| A | 7 (46.7%) |
| B | 2 (13.3%) |
| C | 1 (6.7%) |
| D | 5 (33.3%) |
| Chronic/Acute SCIc | Chronic SCI (15; 100%) |